Skip to primary navigation
Skip to main content
Skip to primary sidebar
Skip to footer
Medinice
About Medinice
About Medinice
Medtech Market
Company Management
EU funds
Projects
PacePress
CoolCryo
AtriClamp
MiniMax
EP Bioptom
Investor Relations
Investor Relations
ESPI
ESPI
Periodic reports
EIB reports
Analytics
Company Management
General meeting
Corporate governance
Newsroom
Cooperation
Contact
EN
PL
Medinice planuje w 2023 r. zakończyć fazę badań klinicznych w PacePress
2023-12-14
by
iLabs - Kaśka
